Ngā hua rapu - Nancy Krett
- E whakaatu ana i te 1 - 12 hua o te 12
-
1
-
2
-
3
-
4
The Selective Protein Kinase C β Inhibitor Enzastaurin Induces Apoptosis in Cutaneous T-Cell Lymphoma Cell Lines through the AKT Pathway mā Christiane Querfeld, Mujahid A. Rizvi, Timothy M. Kuzel, Joan Guitart, Alfred Rademaker, Simran S. Sabharwal, Nancy Krett, Steven T. Rosen
I whakaputaina 2006Artigo -
5
-
6
-
7
Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines mā Mujahid A. Rizvi, Kulsoom Ghias, Katharine M. Davies, Chunguang Ma, Frank Weinberg, Hidayatullah G. Munshi, Nancy Krett, Steven T. Rosen
I whakaputaina 2006Artigo -
8
Nuclear translocation of Atox1 potentiates activin A-induced cell migration and colony formation in colon cancer mā Arundhati Jana, Archita Das, Nancy Krett, Grace Guzman, Alexandra Thomas, Georgina Mancinelli, Jessica Bauer, Masuko Ushio‐Fukai, Tohru Fukai, Barbara Jung
I whakaputaina 2020Artigo -
9
Increased stiffness of the tumor microenvironment in colon cancer stimulates cancer associated fibroblast-mediated prometastatic activin A signaling mā Jessica Bauer, Bashar Emon, Jonas J. Staudacher, Alexandra Thomas, Jasmin Zessner‐Spitzenberg, Georgina Mancinelli, Nancy Krett, M. Taher A. Saif, Barbara Jung
I whakaputaina 2020Artigo -
10
NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway mā Arundhati Jana, Nancy Krett, Grace Guzman, Ahmer Khalid, Özkan Özden, Jonas J. Staudacher, Jessica Bauer, Ron Baik, Timothy Carroll, Cemal Yazıcı, Barbara Jung
I whakaputaina 2017Artigo -
11
Activin signaling is an essential component of the TGF-β induced pro-metastatic phenotype in colorectal cancer mā Jonas J. Staudacher, Jessica Bauer, Arundhati Jana, Jun Tian, Timothy Carroll, Georgina Mancinelli, Özkan Özden, Nancy Krett, Grace Guzman, David Kerr, Paul J. Grippo, Barbara Jung
I whakaputaina 2017Artigo -
12
An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resista... mā Lauren A. Byers, Lixia Diao, Jing Wang, Pierre Saintigny, Luc Girard, Michael Peyton, Li Shen, You-Hong Fan, Uma Giri, Praveen K. Tumula, Monique B. Nilsson, Jayanthi Gudikote, Hai T. Tran, Robert J. Cardnell, David J. Bearss, Steven L. Warner, Jason M. Foulks, Steven B. Kanner, Varsha Gandhi, Nancy Krett, Steven T. Rosen, Edward S. Kim, Roy S. Herbst, George R. Blumenschein, J. Jack Lee, Scott M. Lippman, K. Kian Ang, Gordon B. Mills, Waun Ki Hong, John N. Weinstein, Ignacio I. Wistuba, Kevin R. Coombes, John D. Minna, John V. Heymach
I whakaputaina 2012Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Cancer research
Biochemistry
Cancer
Cell biology
Genetics
Internal medicine
Medicine
Signal transduction
Apoptosis
Chemistry
Colorectal cancer
Gene
Cell culture
PI3K/AKT/mTOR pathway
Immunology
Metastasis
Multiple myeloma
Activin type 2 receptors
Downregulation and upregulation
Endocrinology
Epidermal growth factor receptor
Epithelial–mesenchymal transition
Gene expression
Oncology
Protein kinase B
TGF beta signaling pathway
Transforming growth factor
ACVR2B
ACVRL1